首页> 外文会议>International Carbohydrate Symposium >PDA-BASED NANOMICELLES FOR THE DIAGNOSIS AND TREATMENT OF HEPATIC AND PROSTATE CANCER
【24h】

PDA-BASED NANOMICELLES FOR THE DIAGNOSIS AND TREATMENT OF HEPATIC AND PROSTATE CANCER

机译:基于PDA的纳米钙,用于肝癌和前列腺癌的诊断和治疗

获取原文

摘要

Cancer is one of the chronic diseases with worse prognosis and whose treatment still implies harmful side effects. Among the different approaches developed so far against this threat, nanomedicine is the most promising one for the development of efficient therapeutic and diagnostic (theranostic) agents. Thus, the design and synthesis of nanovectors that allow the targeted delivery of anticancer drugs and imaging agents, is highly needed. Based on these premises, in the present work we report on the design and synthesis of mannose-, galactose- and a dipeptide-coated nanomicelles for their application as smart nanovectors for drug delivery into hepatic and prostate cancers (see Fig. 1). These nanomicelles are easily produced by a simple method through the supramolecular self-organization and photo-polymerization of diacetylenic-based amphiphiles pre-functionalized with the desired specific ligand [1]. The polymerization which takes place without catalyst or initiators afford in pure form micelles unaffected by the dilution.
机译:癌症是预后较差的慢性疾病之一,其治疗仍然意味着有害的副作用。在迄今为止发生这种威胁的不同方法中,纳米医生是最有前途的一种用于开发有效的治疗和诊断(治疗)药剂。因此,非常需要设计和合成允许靶向递送抗癌药物和成像剂的纳米液体。基于这些场所,在本工作中,我们报告了甘露糖,半乳糖和二肽涂覆的纳米乳蛋白的设计和合成,其应用作为智能纳米液体,用于药物输送到肝脏和前列腺癌(见图1)。通过使用所需特异性配体预制化的超分子自组织和基于二乙炔基两亲的光聚合的简单方法容易地生产这些纳米钙。在没有催化剂或引发剂的情况下发生的聚合,其在纯的胶束中不受稀释的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号